These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8790307)

  • 21. Comparable long-term survival after bone marrow versus peripheral blood progenitor cell transplantation from matched unrelated donors in children with hematologic malignancies.
    Meisel R; Laws HJ; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Schmitz M; Fischer J; Göbel U; Enczmann J; Dilloo D
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1338-45. PubMed ID: 17950920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone marrow transplantation using HLA-matched unrelated donors for patients suffering from severe combined immunodeficiency.
    Grunebaum E; Roifman CM
    Immunol Allergy Clin North Am; 2010 Feb; 30(1):63-73. PubMed ID: 20113887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allogeneic bone marrow transplantation for chronic myelomonocytic leukemia in childhood: a report from the European Working Group on Myelodysplastic Syndrome in Childhood.
    Locatelli F; Niemeyer C; Angelucci E; Bender-Götze C; Burdach S; Ebell W; Friedrich W; Hasle H; Hermann J; Jacobsen N; Klingebiel T; Kremens B; Mann G; Pession A; Peters C; Schmid HJ; Stary J; Suttorp M; Uderzo C; van't Veer-Korthof ET; Vossen J; Zecca M; Zimmermann M
    J Clin Oncol; 1997 Feb; 15(2):566-73. PubMed ID: 9053478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allogeneic bone marrow transplantation in children from other than HLA-identical sibling donor.
    Locatelli F; Bongiorno M; Zecca M; Giani S; Giorgiani G; Guagnini R; Morandi P; Porta F; Nespoli L; Burgio GR
    Bone Marrow Transplant; 1991; 7 Suppl 3():124-7. PubMed ID: 1855074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Equivalent outcomes in patients with chronic myelogenous leukemia after early transplantation of phenotypically matched bone marrow from related or unrelated donors.
    Davies SM; DeFor TE; McGlave PB; Miller JS; Verfaillie CM; Wagner JE; Weisdorf DJ
    Am J Med; 2001 Apr; 110(5):339-46. PubMed ID: 11286947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allogeneic bone marrow transplantation using unrelated donors: a pilot study of the Canadian Bone Marrow Transplant Group.
    Phillips GL; Barnett MJ; Brain MC; Chan KW; Huebsch LB; Klingemann HG; Meharchand J; Reece DE; Rybka WB; Shepherd JD
    Bone Marrow Transplant; 1991 Dec; 8(6):477-87. PubMed ID: 1790428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved graft-versus-host disease-free, relapse-free survival associated with bone marrow as the stem cell source in adults.
    Mehta RS; Peffault de Latour R; DeFor TE; Robin M; Lazaryan A; Xhaard A; Bejanyan N; de Fontbrune FS; Arora M; Brunstein CG; Blazar BR; Weisdorf DJ; MacMillan ML; Socie G; Holtan SG
    Haematologica; 2016 Jun; 101(6):764-72. PubMed ID: 27036159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized placebo-controlled trial of lisofylline in HLA-identical, sibling-donor, allogeneic bone marrow transplant recipients. The Lisofylline Marrow Transplant Study Group.
    List AF; Maziarz R; Stiff P; Jansen J; Liesveld J; Andrews F; Schuster M; Wolff S; Litzow M; Karanes C; Dahlberg S; Kirkhart B; Bianco JA; Singer JW
    Bone Marrow Transplant; 2000 Feb; 25(3):283-91. PubMed ID: 10673700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Present-day evaluation of allogeneic bone marrow transplantation].
    Gluckman E
    Pathol Biol (Paris); 1980 Jan; 28(1):5-7. PubMed ID: 6987595
    [No Abstract]   [Full Text] [Related]  

  • 30. Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the French Society of Bone Marrow Transplantation and Cell Therapy.
    Yakoub-Agha I; Mesnil F; Kuentz M; Boiron JM; Ifrah N; Milpied N; Chehata S; Esperou H; Vernant JP; Michallet M; Buzyn A; Gratecos N; Cahn JY; Bourhis JH; Chir Z; Raffoux C; Socié G; Golmard JL; Jouet JP;
    J Clin Oncol; 2006 Dec; 24(36):5695-702. PubMed ID: 17116940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II Study of Nonmyeloablative Allogeneic Bone Marrow Transplantation for B Cell Lymphoma with Post-Transplantation Rituximab and Donor Selection Based First on Non-HLA Factors.
    Kanakry JA; Gocke CD; Bolaños-Meade J; Gladstone DE; Swinnen LJ; Blackford AL; Fuchs EJ; Huff CA; Borrello I; Matsui WH; Brodsky RA; Rosner GL; Shanbhag S; Luznik L; Jones RJ; Ambinder RF; Kasamon YL
    Biol Blood Marrow Transplant; 2015 Dec; 21(12):2115-2122. PubMed ID: 26183076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Probability of finding a compatible sibling donor for bone marrow transplantation in Ireland.
    O'Riordan J; Finch A; Lawlor E; McCann SR
    Bone Marrow Transplant; 1992 Jan; 9(1):27-30. PubMed ID: 1531937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Major Histocompatibility Mismatch and Donor Choice for Second Allogeneic Bone Marrow Transplantation.
    Imus PH; Blackford AL; Bettinotti M; Iglehart B; Dietrich A; Tucker N; Symons H; Cooke KR; Luznik L; Fuchs EJ; Brodsky RA; Matsui WH; Huff CA; Gladstone D; Ambinder RF; Borrello IM; Swinnen LJ; Jones RJ; Bolaños-Meade J
    Biol Blood Marrow Transplant; 2017 Nov; 23(11):1887-1894. PubMed ID: 28754545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allogeneic unrelated bone marrow transplantation from older donors results in worse prognosis in recipients with aplastic anemia.
    Arai Y; Kondo T; Yamazaki H; Takenaka K; Sugita J; Kobayashi T; Ozawa Y; Uchida N; Iwato K; Kobayashi N; Takahashi Y; Ishiyama K; Fukuda T; Ichinohe T; Atsuta Y; Mori T; Teshima T;
    Haematologica; 2016 May; 101(5):644-52. PubMed ID: 26858357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Selection of an unrelated donor for hematopoietic stem cell transplantation. HLA haplotypes in patients with blood system diseases].
    Khamaganova EG; Parovichnikova EN; Kuz'mina LA; Gemdzhian ÉG; Chugreeva TP; Iushkova AA
    Ter Arkh; 2014; 86(7):31-6. PubMed ID: 25314775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allogeneic marrow transplantation: the Seattle experience.
    Hansen JA; Anasetti C; Martin PJ; Mickelson EM; Petersdorf E; Thomas ED
    Clin Transpl; 1993; ():193-209. PubMed ID: 7918153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allogeneic bone marrow transplantation in multiple myeloma. European Group for Bone Marrow Transplantation.
    Gahrton G; Tura S; Ljungman P; Belanger C; Brandt L; Cavo M; Facon T; Granena A; Gore M; Gratwohl A
    N Engl J Med; 1991 Oct; 325(18):1267-73. PubMed ID: 1922221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP).
    Michel G; Leverger G; Leblanc T; Nelken B; Baruchel A; Landman-Parker J; Thuret I; Bergeron C; Bordigoni P; Esperou-Bourdeau H; Perel Y; Vannier JP; Schaison G
    Bone Marrow Transplant; 1996 Feb; 17(2):191-6. PubMed ID: 8640165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allograft and autograft purging using immunotoxins in clinical bone marrow transplantation for hematologic malignancies.
    Uckun FM; Myers DE
    J Hematother; 1993; 2(2):155-63. PubMed ID: 7921971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of childhood leukemia with unrelated donor allogeneic bone marrow transplantation].
    Huang H; Cai Z; Lin MF; Xie WZ; Liang B; Li L; He JS; Luo Y; Zheng WY; Zhang J; Ye XJ; Hu XR; Chen SY; Jin AY
    Zhonghua Er Ke Za Zhi; 2004 Nov; 42(11):835-9. PubMed ID: 15631711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.